Bank of America’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.79M Buy
6,034,147
+5,909,158
+4,728% +$4.21M ﹤0.01% 3599
2026
Q1
$57.1K Sell
124,989
-1,067,247
-90% -$984K ﹤0.01% 5583
2025
Q4
$2.62M Buy
1,192,236
+1,103,602
+1,245% +$1.78M ﹤0.01% 3855
2025
Q3
$141K Buy
88,634
+16,856
+23% +$21.9K ﹤0.01% 6441
2025
Q2
$116K Buy
71,778
+603
+0.8% +$974 ﹤0.01% 6456
2025
Q1
$84.7K Buy
71,175
+5,562
+8% +$8.88K ﹤0.01% 6568
2024
Q4
$135K Sell
65,613
-26,192
-29% -$61K ﹤0.01% 6279
2024
Q3
$232K Buy
91,805
+51,221
+126% +$167K ﹤0.01% 5925
2024
Q2
$173K Buy
40,584
+16,988
+72% +$109K ﹤0.01% 5961
2024
Q1
$175K Buy
+23,596
New +$199K ﹤0.01% 5955

Other funds holding GUTS

Bank of America's GUTS Position: Q2 2026 in Review

Bank of America increased its Fractyl Health (GUTS) stake by 4,728% in Q2 2026, buying an estimated $4.21M and bringing the position to 6,034,147 shares worth $4.79M. The position accounts for ﹤0.01% of the portfolio, ranked #3599.

Bank of America first reported a position in GUTS in Q1 2024 and has held it in 10 quarters since. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • Bank of America held 6,034,147 shares of Fractyl Health worth $4.79M as of Q2 2026.
  • Bank of America bought 5,909,158 Fractyl Health shares in Q2 2026, an estimated $4.21M.
  • Fractyl Health made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #3599 holding.
  • Bank of America first reported a position in Fractyl Health in Q1 2024 and has held it in 10 quarters since.
  • 77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.